Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme

By sjmartinez • February 1, 2023

Dougados M, Charles-Schoeman C, Szekanecz Z, Giles JT, Ytterberg SR, Bhatt DL, Koch GG, Vranic I, Wu J, Wang C, Kwok K, Menon S, Connell CA, Yndestad A, Rivas JL, Buch MH. Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme. Ann Rheum Dis. 2023 Jan 31:ard-2022-223406. doi: 10.1136/ard-2022-223406. Epub ahead of print. PMID: 36720582.

Tags: Antirheumatic Agents, Arthritis, cardiovascular diseases, Publications, Rheumatoid, Rheumatology

A comprehensive assessment of post-discharge antibiotic use across an integrated healthcare system

Livorsi DJ, Goetz MB, Alexander B, Beck B, Wardyn SE, Murray SC, Goto M. A comprehensive assessment of post-discharge antibiotic use across an integrated healthcare[...]

Early-Onset Polyarticular Gout: A Case Report

Kose L. Early-Onset Polyarticular Gout: A Case Report. Cureus. 2025 Aug 15;17(8):e90199. doi: 10.7759/cureus.90199. PMID: 40959331; PMCID: PMC12434384.

Vibratory Angioedema Due to Vigorous Nose Blowing: A Case Report

Truong T, Kaddis T, Wang V, Tsai M, Yusin J. Vibratory Angioedema Due to Vigorous Nose Blowing: A Case Report. Cureus. 2025 Aug 15;17(8):e90197. doi:[...]